MedPath

江苏神曲医药有限公司

Ownership
-
Established
2005-01-12
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Gemcitabine Hydrochloride for Injection

Product Name
注射用盐酸吉西他滨
Approval Number
国药准字H20249831
Approval Date
Dec 25, 2024
NMPA

Pemetrexed Disodium for Injection

Product Name
注射用培美曲塞二钠
Approval Number
国药准字H20249345
Approval Date
Nov 15, 2024
NMPA

神曲牌芦荟当归胶囊

Approval Number
国食健注G20130818
Approval Date
Jan 25, 2022
NMPA

神曲牌黄精枸杞胶囊

Approval Number
国食健注G20120134
Approval Date
Jan 21, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.